125
|
High Dose Oral Rifampicin to Improve Survival from Adult Tuberculous Meningitis: A Double-blinded Randomised Controlled Phase III Trial
|
1. dr. Darma Imran, Sp.S(K) 2. Dr. dr. Riwanti Estiasari, Sp.S(K) 3. dr. Kartika Maharani, Sp.N(K) |
Infectious Diseases Institute, Uganda |
High Dose Oral Rifampicin to Improve Survival from Adult Tuberculous Meningitis: A Double-blinded Randomised Controlled Phase III Trial
|
USA,Uganda,South Africa,Indonesia(Neurologi FKUI,oucru,unpad),Minneapolis,London,Netherland,Vietnam |
Oxford University Clinical Research Unit (OUCRU) |
High Dose Oral Rifampicin |
- Infectious Diseases Institute - UNPAD- Centre for the AIDS programme of research in South Africa (CAPRISA) - OUCRU- Radboud University - University of Minnesota - University of KwaZulu-Natal - St. George’s University Hospital - Johns Hopkins University |
|
|